+

PE20030360A1 - Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion - Google Patents

Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion

Info

Publication number
PE20030360A1
PE20030360A1 PE2002000806A PE2002000806A PE20030360A1 PE 20030360 A1 PE20030360 A1 PE 20030360A1 PE 2002000806 A PE2002000806 A PE 2002000806A PE 2002000806 A PE2002000806 A PE 2002000806A PE 20030360 A1 PE20030360 A1 PE 20030360A1
Authority
PE
Peru
Prior art keywords
indan
alkyl
onas
derivatives
substituted
Prior art date
Application number
PE2002000806A
Other languages
English (en)
Inventor
Martin Bickel
Volker Krone
Gerhard Jaehne
Matthias Gossel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PE20030360A1 publication Critical patent/PE20030360A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/24Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE INDAN-1-ONAS SUSTITUIDAS EN C2 Y SUS DERIVADOS DE FORMULA I DONDE: a) R1-R4 SON H; X ES S, SO, SO2; Y ES (CH2)p DONDE p PUEDE SER 0-3; R5 ES CF3, ALQUILO C2-C18, CICLOALQUILO C3-C4, CICLOALQUILO C6-C8, DONDE LOS GRUPOS ALQUILO PUEDEN ESTAR REEMPLAZADOS CON F; b) R1 Y R4 SON H, F, Cl, Br, I, CH, N3, NO2, OH, ENTRE OTROS, R2 Y R3 SON H, F, Cl, Br, I, CH, N3, OALQUILO C1-C8, OCICLOALQUILO C3-C8, O-CO-ALQUILO C1-C8, ENTRE OTROS, R2 Y R3 JUNTOS FORMAN EL GRUPO -O-CH2-O-, ENTRE OTROS, R4 ES DIFERENTE DE H, X ES S, SO, SO2, R5 ES ALQUILO C1-C18, CICLAOLQUILO C3-C4 Y C6-C8 , ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y COMPUESTOS INTERMEDIOS. SON COMPUESTOS PREFERIDOS 5-CLORO-2-METILSULFANIL-INDAN-1-ONA, 5-CLORO-2-METANOSULFONIL-INDAN-1-ONA, 5-CLORO-2-FENILSULFANIL-INDAN-1-ONA, ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON UTILES PARA EL TRATAMIENTO O PROFILAXIS DE OBESIDAD, DIABETES TIPO II
PE2002000806A 2001-08-31 2002-08-22 Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion PE20030360A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10142722A DE10142722A1 (de) 2001-08-31 2001-08-31 C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PE20030360A1 true PE20030360A1 (es) 2003-05-16

Family

ID=7697277

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000806A PE20030360A1 (es) 2001-08-31 2002-08-22 Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion

Country Status (12)

Country Link
US (1) US6762326B2 (es)
EP (1) EP1425267B1 (es)
JP (1) JP4280164B2 (es)
AR (1) AR036675A1 (es)
AT (1) ATE472525T1 (es)
AU (1) AU2002336085B2 (es)
CA (1) CA2458528C (es)
DE (2) DE10142722A1 (es)
IL (1) IL160608A0 (es)
MX (1) MXPA04001846A (es)
PE (1) PE20030360A1 (es)
WO (1) WO2003020677A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920393D0 (en) 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
US7659313B2 (en) 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7700500L (sv) * 1976-01-20 1977-07-21 Hoechst Ag Tiazolidinderivat och forfarande for deras framstellning
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
EP0009554B1 (de) * 1978-07-27 1983-04-27 Schering Aktiengesellschaft Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
RU2073673C1 (ru) * 1987-10-19 1997-02-20 Пфайзер Инк. Рацемические и оптические активные производные тетралина и 7-гидрокситетралина
ATE163930T1 (de) * 1993-01-29 1998-03-15 American Cyanamid Co Aminocycloalkanobenzodioxole als beta-3 selektive adrenergische wirkstoffe
IL124756A0 (en) * 1995-12-06 1999-01-26 Venantius Limited Indane dimer compounds and their pharmaceutical use
WO1997026265A1 (en) 1996-01-17 1997-07-24 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
PT944648E (pt) 1996-08-30 2007-06-26 Novo Nordisk As Derivados do glp-1.
IL127296A (en) 1996-12-31 2003-01-12 Reddy Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
HUP0003999A3 (en) 1997-07-16 2003-03-28 Novo Nordisk As Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2796070B1 (fr) * 1999-07-06 2003-02-21 Lipha Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
EP1078632A1 (en) 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity

Also Published As

Publication number Publication date
WO2003020677A2 (de) 2003-03-13
JP2005525295A (ja) 2005-08-25
MXPA04001846A (es) 2004-06-15
AU2002336085B2 (en) 2007-10-11
CA2458528A1 (en) 2003-03-13
US20030130345A1 (en) 2003-07-10
AR036675A1 (es) 2004-09-29
CA2458528C (en) 2011-01-25
US6762326B2 (en) 2004-07-13
JP4280164B2 (ja) 2009-06-17
IL160608A0 (en) 2004-07-25
EP1425267B1 (de) 2010-06-30
DE10142722A1 (de) 2003-03-27
WO2003020677A3 (de) 2003-07-31
DE50214511D1 (de) 2010-08-12
EP1425267A2 (de) 2004-06-09
ATE472525T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
PE20050142A1 (es) 2-hidroxi-3-diaminoalcanos de benzamida
PE69298A1 (es) Inhibidores de metaloproteinasas, composiciones farmaceuticas que los contienen y sus usos farmaceuticos y los metodos e intermedios utiles para su preparacion
ATE40122T1 (de) N-(2-nitrophenyl)-2-aminopyrimidin-derivate, deren herstellung und verwendung.
AR037901A1 (es) Beta-amino-alfa-cianoacrilatos
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
SE0300956L (sv) Stabilisatorblandningar
PE20060689A1 (es) Derivados de sulfonamidas como antagonistas de receptores orexina 2
CY1110651T1 (el) Παραγωγα της ν-'(1,5-διφαινυλ-1η- πυραζολ-3-υλ)μεθυλ σουλφοναμιδης με μια συγγενεια για τους υποδοχεις cb1
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
PE20071254A1 (es) Derivados de sulfonamidas como agentes moduladores de los receptores de orexina y su preparacion
ECSP920893A (es) Derivados de 2-imidazolin - 5 onas y 2-imidazolin -5-tionas con propiedades fungicidas
PE20020195A1 (es) AGONISTAS ß3 ADRENERGICOS
DK130584D0 (da) N-(2-nitrophenyl)-4-amino-pyrimidin-derivater samt deres fremstilling og anvendelse som mikrobicider
SV2009002925A (es) Derivados de oxadiazol
PE20001063A1 (es) Nuevos agentes antibacterianos de isoxazolinona
CO5640041A2 (es) Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
PE20081504A1 (es) Compuestos de biciclocarboxiamida sustituidos
NO20076402L (no) Imaging 18F or 11C-labelled alkylthiophenyl guanidines
AR043487A1 (es) Heterociclos fusionados de pirimidina y usos de los mismos
EA201000881A1 (ru) Пиридилметил-сульфонамидные соединения
PE20061446A1 (es) Compuestos de bencimidazol-carboxamida como agonistas de receptores 5-ht4
CL2022003625A1 (es) Compuestos naftaleno isoxazolina para controlar plagas invertebradas (divisional de patente de invención no 2073-2020)
ES2317103T3 (es) Derivados de c-ciclohexilmetilamina sustituidos.
PE20030363A1 (es) Utilizacion de sistemas de indan-1-ol varias veces sustituidos, para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad
CO5690578A2 (es) Derivados de acido 4-(3-(2-feniloxazol-4-ilmetoxi)ciclohexiloxi)-butanoico y compuestos relacionados como moduladores de ppar para tratar la diabetes tipo 2 y la aterosclerosis

Legal Events

Date Code Title Description
FC Refusal
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载